FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

LNK International Nighttime Sleep-Aid Recall

Nighttime Sleep-Aid (doxylamine succinate HCl) tablets, 25 mg, 48-count blisters per ca…

LNK International, Inc. · Hauppauge, NY

Risk level
Class III
Reported by FDA
Sep 7, 2022
Recall ID
D-1472-2022
Check your lot numberHow we source this data

Summary

LNK International recalled Nighttime Sleep-Aid starting Aug 4, 2022. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1472-2022 on Sep 7, 2022. Reason: Labeling: Not Elsewhere Classified: Carton incorrectly identifies product as doxylamine succinate HCl, however the product is doxylamine succinate. Status: Terminated.

Why it was recalled

Labeling: Not Elsewhere Classified: Carton incorrectly identifies product as doxylamine succinate HCl, however the product is doxylamine succinate.

Product description

Nighttime Sleep-Aid (doxylamine succinate HCl) tablets, 25 mg, 48-count blisters per carton, Distributed by: CVS Pharmacy, Inc., One CVS Drive, Woonsocket, RI 02895, UPC 0 50428 34873 4.

Lot numbers, UPCs & expiration codes

P121512, exp. date 08/2023; P122015, exp. date 09/2023; P122712, exp. date 11/2023; P123090, exp. date 12/2023; P123170, exp. date 12/2023; P124325, exp. date 03/2024; P124664, exp. date 03/2024; P125165, exp. date 05/2024; P125576, exp. date 06/2024; P125577, exp. date 06/2024; P127089, exp. date 10/2024; P127090, exp. date 10/2024; P127386, exp. date 11/2024; P128572, exp. date 01/2025; P128383, exp. date 01/2025; P129536, exp. date 04/2025

Where it was sold

Product was distributed to one retailer who may have further distributed the product to other distribution sites nationwide in the USA.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1472-2022
Classification
Class III
Status
Terminated
Recall initiated
Aug 4, 2022
FDA report date
Sep 7, 2022
Quantity
257,064 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
LNK International, Inc.

Original FDA data

Every field from FDA enforcement report D-1472-2022, exactly as published.

Show all FDA fields
City
Hauppauge
State
NY
Status
Terminated
Country
United States
Event ID
90708
Address
55 Arkay Dr
Code information
P121512, exp. date 08/2023; P122015, exp. date 09/2023; P122712, exp. date 11/2023; P123090, exp. date 12/2023; P123170, exp. date 12/2023; P124325, exp. date 03/2024; P124664, exp. date 03/2024; P125165, exp. date 05/2024; P125576, exp. date 06/2024; P125577, exp. date 06/2024; P127089, exp. date 10/2024; P127090, exp. date 10/2024; P127386, exp. date 11/2024; P128572, exp. date 01/2025; P128383, exp. date 01/2025; P129536, exp. date 04/2025
Postal code
11788-3707
Report date
Sep 7, 2022
Product type
Drugs
Recall number
D-1472-2022
Classification
Class III
Recalling firm
LNK International, Inc.
Product quantity
257,064 cartons
Termination date
Mar 3, 2023
Reason for recall
Labeling: Not Elsewhere Classified: Carton incorrectly identifies product as doxylamine succinate HCl, however the product is doxylamine succinate.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Nighttime Sleep-Aid (doxylamine succinate HCl) tablets, 25 mg, 48-count blisters per carton, Distributed by: CVS Pharmacy, Inc., One CVS Drive, Woonsocket, RI 02895, UPC 0 50428 34873 4.
Distribution pattern
Product was distributed to one retailer who may have further distributed the product to other distribution sites nationwide in the USA.
Recall initiation date
Aug 4, 2022
Initial firm notification
Letter
Center classification date
Aug 30, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1472-2022, published Sep 7, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls